International Mesothelioma Conference Will Kick Off at UCLA

Thoracic surgeon and renowned mesothelioma specialist Dr. Robert Cameron will be hosting the 6th International Symposium on Malignant Pleural Mesothelioma on Saturday, Sept. 24, at the UCLA School of Medicine. Cameron, director of the UCLA Comprehensive Mesothelioma Program, is a global leader in the development of the lung-sparing pleurectomy/decortication surgery and a vocal advocate for military veterans who develop the asbestos-related disease. The conference will cover the latest in mesothelioma therapeutics, including novel immunotherapies, gene therapy, upcoming clinical trials and surgical advancements. The purpose is to improve the understanding of multidisciplinary treatment, learn about adjuvant therapy possibilities, raise awareness to various types of immunological therapies, and emphasize the need to treat mesothelioma as a chronic disease. Oncologists, pulmonologists, surgeons, nurses, medical students, mesothelioma advocates, patients and families across the nation will attend to exchange thoughts and ideas. The Mesothelioma Center’s Patient Advocates Karen Selby and Vanessa Blanco will participate, ensuring patients and loved ones who reach out to the organization in the coming months will receive the latest information on mesothelioma treatments. Selby, a registered nurse with a surgical and oncological background, joined The Mesothelioma Center in 2009. “It’s important for us to be there, hearing about the cutting-edge research and learni...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: 216 mesothelioma conference in california international mesothelioma conference International Symposium on Malignant Pleural Mesothelioma robert cameron UCLA Comprehensive Mesothelioma Program Source Type: news

Related Links:

An underground steam pipe explosion and the resulting fountain of vapor filled with toxic asbestos fibers caused the evacuation of 28 buildings and the closing of several surrounding streets in New York City Thursday. Only five minor injuries were reported, but the force of the blast and the steady stream of smoke pouring from the resulting crater covered nearby buildings and sent commuters running for shelter. The fear of asbestos contamination dominated the early cleanup efforts. Inhaling or ingesting microscopic asbestos fibers can eventually lead to serious health problems, including asbestosis, lung cancer and mesothe...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
In this study we investigate the significance of BAP1 in canine melanoma. Nuclear BAP1 protein was detected in five canine oral melanoma cell lines using an antibody commonly used for analysis of human tissues. BAP1 loss of function mutations often lead to loss of nuclear BAP1 (nBAP1) expression in humans; this is associated with a poorer prognosis in uveal and mucosal melanoma. Therefore, as a prelude to a study evaluating the prognostic significance of nBAP1 expression in dogs, immunohistochemistry (IHC) was used to assess cases of canine melanoma for nBAP1 expression. In 89 cases where tumour cells were identified by me...
Source: Journal of Comparative Pathology - Category: Pathology Source Type: research
It has been several years since Federal Drug Administration (FDA) approval of a new cytotoxic in thoracic malignancies. Nab-paclitaxel was approved for non-small-cell lung cancer (NSCLC) in 2012, pemetrexed for malignant pleural mesothelioma (MPM) in 2004 and topotecan for small-cell lung cancer (SCLC) in 1998. In the first half of the current decade targeted therapy was the major advancement and in the latter half of this decade immunotherapy has been the focus. Antibody-drug conjugates (ADCs) are a new type of cytotoxic, which target particular cancer cell surface proteins and may aid in stimulating anti-tumor immunity.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine added to cisplatin when these drugs are delivered together as heated intraoperative chemotherapy (HIOC) during surgery. Researchers have studied cisplatin alone for HIOC. The addition of gemcitabine — a chemotherapy drug often used to treat pancreatic, ovarian and breast cancers — is new. The Journal of Thoracic Oncology...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
You're reading Toxins In The Home: What You Don’t Know Might Kill You, originally posted on Pick the Brain | Motivation and Self Improvement. If you're enjoying this, please visit our site for more inspirational articles. Poisoning is the number one cause of injury-related deaths in the United States, and 91% of incidents occur in our very own homes. Unintentional poisoning can occur in a number of ways, potentially harming our health as well as our loved ones. In an effort to reduce the number of households affected, it’s important to understand where common toxic products might be lurking and how to create a ...
Source: PickTheBrain | Motivation and Self Improvement - Category: Consumer Health News Authors: Tags: featured health and fitness self improvement asbestos cancer cleaning products pickthebrain toxins toxins in the home Source Type: blogs
Malignant peritoneal mesothelioma (MPeM) is an incurable cancer with poor prognosis and several biomarkers have been suggested for screening of MPeM. The aim of our study was to evaluate the prognostic significanceas of IMP3 and Fli-1 in MPeM. Diagnostic biopsies of 44 MPeM patients were centrally collected and were immunohistochemically analyzed for expression of IMP3, Fli-1, and Ki-67. Labelling was assessed by two pathologists. Complete clinical information and follow up were obtained from patients' records.
Source: Human Pathology - Category: Pathology Authors: Tags: Original Contributions Source Type: research
This study was not designed to explain whether supplementing with vitamin D will protect against asbestosis. This new research also does not examine if taking vitamin D will slow down the progression of existing ILD. Still, there are a lot of good reasons to pay attention to the sunshine vitamin. Regardless of whether a person has been exposed to asbestos, no one should ignore very low vitamin D levels. People already diagnosed with an asbestos-related cancer, may benefit from a quick check of vitamin D levels. According to the medical literature, up to 80 percent of people with cancer may be vitamin D deficient. People ca...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
(CNN) — After 8 hours of deliberations Thursday, a St. Louis jury awarded $4.69 billion to 22 women who sued pharmaceutical giant Johnson &Johnson alleging their ovarian cancer was caused by using its powder as a part of their daily feminine hygiene routine. The jury award includes $550 million in compensatory damages and $4.14 billion in punitive damages. It’s the largest verdict against the company that has sold Baby Powder and Shower to Shower brand talcum powder for decades. The jurors sat through weeks of testimony listening to experts who explained the complicated science, workers at Johnson &John...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Johnson & Johnson Local TV Source Type: news
A Missouri jury Thursday ordered Johnson &Johnson to pay $4.69 billion to 22 women who claim asbestos in the company’s talc products caused them to develop ovarian cancer. It is the largest verdict to date the consumer goods giant has faced in an asbestos-talc case. The Circuit Court of the City of St. Louis handed down $550 million in compensatory damages and $4.14 billion in punitive damages in the verdict, averaging about $25 million apiece for the 22 plaintiffs. J&J currently faces roughly 9,000 cases that blame its talc products — including the company’s iconic Johnson’s Baby Powder —...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
We describe a patient with a family history of peritoneal mesothelioma, who develop...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Review Source Type: research
More News: Allergy & Immunology | Asbestosis | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular & Thoracic Surgery | Clinical Trials | Conferences | Environmental Health | Gene Therapy | Genetics | Heart | Immunotherapy | Learning | Mesothelioma | New York University | Nurses | Nursing | Students | Universities & Medical Training